Effect of filgrastim (G-CSF) during chemotherapy and abdomino-pelvic radiation therapy in patients with ovarian carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 41, Issue 4, 1998, Pages 843-847

  Fyles, Anthony W ^a,b   Manchul, Lee ^a,b   Levin, Wilf ^a,b   Robertson, John M ^c   Sturgeon, Jeremy ^a   Tsuji, Debbie ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Filgrastim; Myelosuppression; Neutropenia; Ovarian cancer; Radiotherapy

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; BONE PAIN; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; FEMALE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; NEUTROPENIA; OVARY CARCINOMA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RASH; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTOPENIA;

ABDOMEN; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COHORT STUDIES; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; FEMALE; FILGRASTIM; HUMANS; MIDDLE AGED; NEUTROPENIA; OVARIAN NEOPLASMS; PELVIS; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; THROMBOCYTOPENIA;

EID: 0031804143     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00093-5     Document Type: Article

References (19)

1. Fyles A.W., Dembo A.J., Bush R.S., Levin W., Manchul L.A., Pringle J.F., Rawlings G.A., Sturgeon J.F.G., Thomas G.M., Simm J. Analysis of complications in patients treated with abdomino-pelvic radiation therapy for ovarian carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 22:1992;847-851.
2. Barton M.B., Keane T.J., Gadalla T., Maki E. The effect of treatment time and treatment interruption on tumour control following radical radiotherapy of laryngeal cancer. Radiother. Oncol. 23:1992;137-143.
3. Fyles A., Keane T.J., Barton M., Simm J. The effect of treatment duration in the local control of cervix cancer. Radiother. Oncol. 25:1992;273-279.
4. Lanciano R.M., Pajak T.F., Martz M., Hanks G.E. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation A Patterns of Care study . Int. J. Radiat. Oncol. Biol. Phys. 25:1993;391-397.
5. Withers H.R., Taylor J.M.G., Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 27:1988;131-146.
6. Kehoe S.T., Luesley D.M., Ward K., Chan K.K. In vivo evidence of increased malignant cell proliferation following surgery in ovarian cancer. Int. J. Gynecol. Cancer. 5:1995;121-127.
7. Crawford J., Ozer H., Stoller R., Johnson D., Lyman G., Tabbara I., Kris M., Grous J., Picozzi V., Rausch G., et al. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N. Engl. J. Med. 315:1991;164-170.
8. Lieschke G.J., Burgess A.W. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. N. Engl. J. Med. 327:1992;99-106.
9. MacVittie T.J., Monroy R.L., Patchen M.L., Souza L.M. Therapeutic use of recombinant human G-CSF in a canine model of sublethal and lethal whole-body irradiation. Int. J. Radiat. Biol. 57:1990;723-736.
10. Schuening F.G., Storb R., Goehle S., Graham T.C., Appelbaum F.R., Hackman R., Souza L.M. Effect of recombinant human granulocyte-colony stimulating factor on hematopoiesis of normal dogs and on hematopoietic recovery after otherwise lethal total body irradiation. Blood. 74:1989;1308-1313.
11. WHO Handbook for reporting results of cancer treatment. 1979;World Health Organization, Geneva.
12. Adamietz I.A., Rosskopf B., Dapper F.D., von Lieven H., Boettcher H.D. Comparison of two strategies for the treatment of radiogenic leukopenia using granulocyte colony stimulating factor. Int. J. Radiat. Oncol. Biol. Phys. 35:1996;61-67.
13. Knox S.J., Fowler S., Marquez C., Hoppe R.T. Effect of Filgrastim (G-CSF) in Hodgkin's disease patients treated with radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 28:1994;445-450.
14. Kolotas C., Zamboglou N., Schnabel T., Bojar H., Wintzer A., Vogt H-G, Schmitt G. Effect of recombinant human granulocyte colony stimulating factor (R-METHUG-CSF) as an adjunct to large-field radiotherapy a phase I study . Int. J. Radiat. Oncol. Biol. Phys. 35:1996;137-142.
15. McManus M.P., McCormick D., Trimble A., Abram W.P. Value of granulocyte colony stimulating factor in radiotherapy induced neutropenia clinical and laboratory studies . Eur. J. Cancer. 31A:1995;302-307.
16. Meropol N.J., Miller L.L., Korn E.L., Braitman L.E., MacDermott M.L., Schuchter L.M. Severe myelosuppresion resulting from concurrent administration of granulocyte colony-stimulating factor and cytotoxic chemotherapy. J. Natl. Cancer Inst. 84:1992;1201-1203.
17. Lieschke G.J., Burgess A.W. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. N. Engl. J. Med. 327:1992;28-35.
18. Glisson B., Komaki R., Lee J.S., Shin D.M., Fossella F., Murphy W.K., Kurie J., Perez-Soler R., Schea R., Vadhan-Raj S. Integration of filgrastim into chemoradiation for limited small cell lung cancer A Phase I study . Int. J. Radiat. Oncol. Biol. Phys. 40:1998;331-336.
19. Thames H.D., Ruifrok A.C.C., Milas L., Hunter N., Mason K.A., Terry N.H.A., White R.A. Accelerated repopulation during fractionated irradiation of a murine ovarian carcinoma Downregulation of apoptosis as a possible mechanism . Int. J. Radiat. Oncol. Biol. Phys. 35:1996;951-962.